Author

David S. Moura

Hospital Universitario Fundación Jiménez DíazORCID 0000-0002-6514-2419Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Clark A. MeyeriD· 2 shared Heather N. HayengaiD· 2 shared Javier Martín‐BrotoiD· 2 shared Jose Lucinio Mondaza-HernandeziD· 2 shared Leonidas G. BlerisiD· 2 shared Alan James StewartiD· 1 shared Alejandro Huerta UribeiD· 1 shared Allan J. B. WatsoniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Clark A. MeyerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer LettersPeer-reviewedMay 22, 2026

NAB2-STAT6 Fusion Proteins Drive Nuclear Condensate Formation and Transcriptional Reprogramming in Solitary Fibrous Tumors

Yi Li, Jose Lucinio Mondaza-Hernandez, Gauthami Pulivendala…·Leonidas G. Bleris

This study shows NAB2-STAT6 fusion proteins form nuclear condensates that drive transcriptional changes in SFT, and Mithramycin A disrupts these condensates.

1 citation

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 15, 2026

L-pentahomoserine correlates with therapy outcome in esophageal cancer and promotes metabolic adaptations that support cell survival under nutrient-deprived conditions

Mark E. Kelly, Alejandro Huerta Uribe, Micheale Cerna…·Victor Hugo Villar

The paper identifies L-pentahomoserine as a bacterial metabolite linked to better survival in esophageal cancer by supporting metabolic adaptations under nutrient stress.

DOI 10.64898/2026.01.15.699640

mousemetabolomics

𝕏 PostBluesky

Cancer BiologyNeoplasiaPeer-reviewedOct 29, 2025

Identification of BET Inhibitors (BETi) Against Solitary Fibrous Tumor (SFT) Through High-Throughput Screening (HTS)

Jose Lucinio Mondaza-Hernandez, David S. Moura, Yi Li…·Heather N. Hayenga

This study identifies BET inhibitors Mivebresib and BMS-986158 as effective anti-SFT agents through high-throughput screening and preclinical models.

2 citations

humanexperimental assay

𝕏 PostBluesky